Friday Pop Quiz 8/14/2026
A 70-year-old female presents for treatment of a large tumor shown on her face. It has been increasing in size for over 10 years. Which of the following medication is FDA approved for locally advanced basal cell carcinoma that is not amenable to surgical therapy?
A. Ipilimumab
B. Sonidegib
C. Erolitinib
D. Interferon alpha
E. 5-fluorouracil
To find out the correct answer and re …
A 70-year-old female presents for treatment of a large tumor shown on her face. It has been increasing in size for over 10 years. Which of the following medication is FDA approved for locally advanced basal cell carcinoma that is not amenable to surgical therapy?
A. Ipilimumab
B. Sonidegib
C. Erolitinib
D. Interferon alpha
E. 5-fluorouracil
To find out the correct answer and re …
Which histologic subtype of the lesion shown is most aggressive?
A. Solid
B. Nodular
C. Superficial
D. Morpheaform
E. All are equal
To find out the correct answer and read the explanation, click here.
…
On dermoscopy, which of the following findings most strongly supports the correct diagnosis?
A. Starburst pattern
B. Blue-whitish veil
C. Maple leaf structures
D. Regression structures
E. Irregular streaks
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partne …
As 2024 comes to a close, the Journal of Drugs in Dermatology delivers a stellar lineup of research, reviews, and insights to inform your practice and inspire your curiosity. This month's Editor's Picks feature cutting-edge studies and expert commentary on a range of topics, from advanced acne treatments to groundbreaking leadership initiatives in dermatology.
Laser and Energy Treatments for Ac …
Cemiplimab is a monoclonal antibody therapy that has emerged as a promising treatment option for certain types of advanced skin cancer. Specifically designed to target the programmed cell death protein 1 (PD-1) pathway, cemiplimab works by blocking the interaction between PD-1 and its ligands, PD-L1 and PD-L2, thereby unleashing the body's immune system to recognize and attack cancer cells. We con …